FDA is Recommending Pausing the Use of Johnson and Johnson Vaccine
FDA is Recommending Pausing the Use of Johnson and Johnson Vaccine in the U.S.

Source: Tom Williams / Getty
The FDA has announced that the distribution of the Johnson & Johnson COVID-19 will be paused after six women in the U.S. had rare blood-clotting after receiving the vaccine. The women were ranging in ages from 18 to 48, and while six people may not seem like a lot precautions are being taken swiftly. There have been approximately 6.8 million shots given with the majority of people not having issues.
The pausing of the Johnson & Johnson vaccine does not affect the other two vaccines from Pfizer and Moderna. But if you did receive the Johnson & Johnson shot and are having to severe stomach pain, leg cramps, or severe headaches you should call your healthcare provider right away. If you do not know what shot you received, check your CDC vaccination card where it is noted what brand shot you received. If you have an appointment scheduled to receive the Johnson & Johnson COVID-19 vaccine, it is advised to call your provider for further directions.
Get Breaking News & Exclusive Contest in Your Inbox:
The Latest:
- He’s bringing real R&B heat—and this time, he’s honoring a legend.
- Tension Boiling Between These Longtime Enemies!!
- Porsha Williams Joins Season 2 of NBC’s “Brilliant Minds” as a wealthy, gossip-loving Housewife
- Trump is building a Lavish $200m gold ballroom in the White House
- Ohio Bill Could Penalize Job Seekers Who Ghost Interviews
- White Florida Couple Racially Harasses, Threatens To Lynch Black Man Just For Knocking On Their Door
- Muni Long Responds to Fans Fat-Shaming and Misdiagnosing Her
- Tonio Armani Brings Southern Soul Vibes at Urban 1 Summit
- ‘It’s for White People’: Trump’s South African Refugee Program Confirms What We Already Knew
- ‘Debilitating’: Justin Timberlake Reveals Lyme Disease Diagnosis